Financials

  • Market Capitalization 29.46 B
  • Employee 11 K
  • Founded 1999
  • CEO Kevin R. Sayer
  • Website www.dexcom.com
  • Headquarter Delaware, United States
  • FIGI BBG000QTF8K1
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
31.76
Price to sales ratio
5.77

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
301
MDLN
Medline Inc. - Class A common stock
40.58 USD-1.12%-5.58%+13.35%+15.94%53.31 B USD
305
EW
Edwards Lifesciences Corporation Common Stock
91.82 USD-0.42%-4.64%+7.99%+16.66%52.87 B USD
487
PHG
Koninklijke Philips N.V. NY Registry Shares
27.33 USD-0.26%-4.04%+3.88%-6.24%27.29 B USD
574
MODD
Modular Medical, Inc. - common stock
3.99 USD0.00%-14.01%-18.74%+470.00%21.60 B USD

Frequently asked questions about DexCom, Inc. - Common Stock

What is the DexCom, Inc. - Common Stock stock price today?

The current price of DexCom, Inc. - Common Stock (DXCM) is 76.35. Over the past 24 hours, the stock has changed by +1.85%. Follow the DXCM chart for real-time price dynamics.

What is the stock ticker of DexCom, Inc. - Common Stock?

DexCom, Inc. - Common Stock trades under the ticker DXCM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is DexCom, Inc. - Common Stock stock going up?

DXCM has changed by +3.39% over the last week, +0.86% over the last month, and -11.25% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was DexCom, Inc. - Common Stock net income for the last quarter?

DexCom, Inc. - Common Stock reported net income of 199.5 M for the last quarter. The previous quarter showed 267.3 M, which means net income changed by -25.36%.

How many employees does DexCom, Inc. - Common Stock have?

As of the latest available data, DexCom, Inc. - Common Stock has 11.1 K employees. Workforce size can provide additional context about the company's scale and operations.

What is DexCom, Inc. - Common Stock EBITDA?

DexCom, Inc. - Common Stock EBITDA is 322.4 M, and its EBITDA margin is 27.05%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy DexCom, Inc. - Common Stock stock?

You can buy DexCom, Inc. - Common Stock (DXCM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in DexCom, Inc. - Common Stock stock?

Investing in DexCom, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DXCM chart and related analysis on metatrader.com as part of your research.

DexCom, Inc. - Common Stock

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.

News